Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials

A Yildiz, E Vieta, S Leucht… - …, 2011 - nature.com
We conducted meta-analyses of findings from randomized, placebo-controlled, short-term
trials for acute mania in manic or mixed states of DSM (III–IV) bipolar I disorder in 56 drug …

The International College of Neuro-Psychopharmacology (CINP) treatment guidelines for bipolar disorder in adults (CINP-BD-2017), part 2: review, grading of the …

KN Fountoulakis, L Yatham, H Grunze… - International Journal …, 2017 - academic.oup.com
Background: The current paper includes a systematic search of the literature, a detailed
presentation of the results, and a grading of treatment options in terms of efficacy and …

Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry

KN Fountoulakis, S Kasper, O Andreassen… - European archives of …, 2012 - Springer
The current statement is a systematic review of the available data concerning the efficacy of
medication treatment of bipolar disorder (BP). A systematic MEDLINE search was made …

A network meta-analysis on comparative efficacy and all-cause discontinuation of antimanic treatments in acute bipolar mania

A Yildiz, M Nikodem, E Vieta, CU Correll… - Psychological …, 2015 - cambridge.org
BackgroundEvidence synthesis methods enabling direct and indirect comparisons over the
entire set of relevant clinical data produce quantitative point estimates for the treatments …

[КНИГА][B] S3-Leitlinie zur Diagnostik und Therapie Bipolarer Störungen

M Bauer, A Pfennig, M Schäfer, P Falkai - 2020 - Springer
Johann Wolfgang von Goethe Diese S3-Leitlinie ist auf Initiative der trialogisch geführten
Deutschen Gesellschaft für Bipolare Störungen eV (DGBS) als gemeinsames Projekt mit der …

Oxcarbazepine for acute affective episodes in bipolar disorder

A Vasudev, K Macritchie, K Vasudev… - Cochrane Database …, 2011 - cochranelibrary.com
Background Oxcarbazepine, a keto derivative of the 'mood stabiliser'carbamazepine, may
have efficacy in the treatment of acute episodes of bipolar disorder. Potentially, it may offer …

Valproate for acute mania

J Jochim, RP Rifkin‐Zybutz, J Geddes… - Cochrane Database …, 1996 - cochranelibrary.com
Background Bipolar disorder is a severe and common mental disorder where patients
experience recurrent symptoms of elevated or irritable mood, depression, or a combination …

[HTML][HTML] Taiwan consensus of pharmacological treatment for bipolar disorder

YM Bai, CJ Chang, SY Tsai, YC Chen, MC Hsiao… - Journal of the Chinese …, 2013 - Elsevier
Bipolar disorder is an important psychiatric disorder with different disease phases. The
pharmacological treatment is complicated, and is updated frequently as new research …

[HTML][HTML] Risk of valproic acid-related alopecia: A systematic review and meta-analysis

X Wang, H Wang, D Xu, L Zhu, L Liu - Seizure, 2019 - Elsevier
Purpose We systematically reviewed studies to provide current evidence about the
incidence and risk of alopecia in patients undergoing valproic acid (VPA) therapy. Methods …